why choose us

First received: November 23, 2022

Clinical Trial: Safety and Tolerability of A3907 in Primary Sclerosing Cholangitis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Primary Sclerosing Cholangitis

Study Type: INTERVENTIONAL


Official Title: An Open Label, Phase 2 Study to Evaluate the Effect of A3907 on Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Adults With Primary Sclerosing Cholangitis (PSC)

Brief Summary: This study will test a drug called A3907 to see how safe and tolerated it is for treating people with Primary Sclerosing Cholangitis (PSC).

Read more